Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGFA Antikörper (N-Term)

VEGFA Reaktivität: Human, Ratte, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN540566
  • Target Alle VEGFA Antikörper anzeigen
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Bindungsspezifität
    • 19
    • 15
    • 15
    • 15
    • 15
    • 15
    • 10
    • 7
    • 7
    • 6
    • 6
    • 6
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 155
    • 125
    • 98
    • 24
    • 20
    • 19
    • 19
    • 16
    • 12
    • 7
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Ratte, Maus
    Wirt
    • 203
    • 54
    • 13
    • 1
    • 1
    Kaninchen
    Klonalität
    • 214
    • 57
    • 1
    Polyklonal
    Konjugat
    • 123
    • 41
    • 25
    • 12
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser VEGFA Antikörper ist unkonjugiert
    Applikation
    • 206
    • 93
    • 65
    • 65
    • 52
    • 31
    • 27
    • 22
    • 22
    • 16
    • 15
    • 12
    • 10
    • 9
    • 8
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of VEGFA.
    Spezifität
    Identical to the related rat sequence.
    Kreuzreaktivität
    Human, Maus, Ratte
    Immunogen
    A synthetic peptide corresponding to amino acids at N-terminus of human VEGFA.
    Isotyp
    IgG
    Top Product
    Discover our top product VEGFA Primärantikörper
  • Applikationshinweise
    Western Blot (0.5-1 μg/mL)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Buffer
    Lyophilized from 0.9 mg NaCl, 0.2 mg Na2HPO4 (5 mg BSA, 0.05 mg sodium azide, 0.05 mg Thimerosal)
    Konservierungsmittel
    Sodium azide, Thimerosal (Merthiolate)
    Vorsichtsmaßnahmen
    This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C on dry atmosphere.
    After reconstitution with 200 uL of deionized water and concentration will be 500 ug/mL, store at -20°C or lower.
    Aliquot to avoid repeated freezing and thawing.
  • Hernandez, Magalhaes, Coniglio, Condeelis, Segall: "Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis." in: Breast cancer research : BCR, Vol. 13, Issue 6, pp. R128, (2012) (PubMed).

    Lee, Link, Baluk, Homer, Chapoval, Bhandari, Kang, Cohn, Kim, McDonald, Elias: "Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung." in: Nature medicine, Vol. 10, Issue 10, pp. 1095-103, (2004) (PubMed).

    Jin, Zhu, Sun, Mao, Xie, Greenberg: "Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 18, pp. 11946-50, (2002) (PubMed).

    Gerber, Malik, Solar, Sherman, Liang, Meng, Hong, Marsters, Ferrara: "VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism." in: Nature, Vol. 417, Issue 6892, pp. 954-8, (2002) (PubMed).

  • Target
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Andere Bezeichnung
    VEGF-A (VEGFA Produkte)
    Synonyme
    MVCD1 antikoerper, VEGF antikoerper, VPF antikoerper, Vegf antikoerper, Vegf120 antikoerper, Vegf164 antikoerper, Vegf188 antikoerper, Vpf antikoerper, vegf antikoerper, vegfa antikoerper, wu:fj82c06 antikoerper, VEGF-A antikoerper, VEGF164 antikoerper, eVEGF120 antikoerper, eVEGF164 antikoerper, vegf-a antikoerper, vpf antikoerper, vefg antikoerper, si:dkey-14d8.3 antikoerper, wu:fd42e02 antikoerper, vascular endothelial growth factor A antikoerper, vascular endothelial growth factor Aa antikoerper, vascular endothelial growth factor A L homeolog antikoerper, vascular endothelial growth factor Ab antikoerper, VEGFA antikoerper, Vegfa antikoerper, vegfaa antikoerper, vegfa.L antikoerper, vegfa antikoerper, vegfab antikoerper
    Gen-ID
    7422
    Pathways
    RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Sie sind hier:
Kundenservice